gvtcx

MHRA Future Activity & Performance Reporting Model

Medicines and Healthcare products Regulatory Agency Published 21 Jul 2025 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£500,000
Statuscomplete
Category (CPV) 79400000
Deadline13 Jun 2025
Contract start10 Jul 2025
Contract end9 Jul 2026
Procedureselective
SME suitableNo
OCIDocds-b5fd17-327b9ea0-570c-43ac-8375-c585a9eba84d

Award

SupplierValueDateStatus
DELOITTE LLP £500,000 9 Jul 2025 active

description

To support our vision to be a world-leading, enabling sovereign regulator - protecting public health through excellence in regulation and science and delivering the right outcomes for patients - we are developing a new MHRA activity and performance reporting model. The provider will collaborate with our internal project team to observe, analyse, optimise, and transform our Management Information.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
21 Jul 2025 Award (award) · 64a67403-7af3-4f8a-a3f4-d0ce9ee05428-855347

more from Medicines and Healthcare products Regulatory Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.